Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
about
Diagnosis and Treatment of Disease Caused by Nontuberculous MycobacteriaClinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteriaManagement of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic SocietyAntibiotic susceptibility pattern of Mycobacterium marinum.A Case of Skin and Soft Tissue Infection Caused by Mycobacterium abscessus.Skin disease and nontuberculous atypical mycobacteria.Disseminated Mycobacterium avium-intracellulare in a kidney transplant recipient.Mycobacterium chelonae/abscessus complex infection in a liver transplant patient.Mycobacterium abscessus infection of a Norplant contraceptive implant site.Treatment of the Mycobacterium chelonae Infection after Fat Injection.Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.Infections in solid-organ transplant recipientsNontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.Atypical mycobacterial infections in children with cancer.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.Macrolides: A Canadian Infectious Disease Society position paper.Lyme disease: the quest for magic bullets.Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication.Detection of autofluorescent Mycobacterium chelonae in living zebrafish.Infection and panniculitis.Nontuberculous mycobacteria infection in solid organ transplant recipients.Endovascular Mycobacterium abscessus infection in a heart transplant recipient: a case report and review of the literature.Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review.Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.In Vitro Antimicrobial Susceptibility of Mycobacterium massiliense Recovered from Wound Samples of Patients Submitted to Arthroscopic and Laparoscopic Surgeries.Rapid-Growing Mycobacteria Infections in Medical Tourists: Our Experience and Literature Review.Non-Tuberculous Mycobacterium: A Rare Cause of Granulomatous Hepatitis.In vitro susceptibility of Mycobacterium ulcerans to clarithromycinGenetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.An immunocompromised dialysis patient with skin and bone lesions.Disseminated Cutaneous Mycobacterium chelonae Infection in a Patient With Acute Myeloid Leukemia.Mycobacterium chelonae skin infection in kidney-pancreas recipient.Clarithromycin resistance to Mycobacterium abscessus.Catheter sepsis due to Mycobacterium chelonae.Disseminated cutaneous Mycobacterium chelonae infection in an immunocompetent host.Successful treatment of disseminated Mycobacterium chelonae infection with linezolid.Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells.
P2860
Q22241907-B4982752-1391-41DF-8D16-1FA6645F2DA7Q24535651-D2C12583-943C-4F03-92E3-EC8B6DE3CC72Q24679338-CB8EA5BE-6970-43DD-9934-DEC4FB3B6A76Q33594611-2F46FF44-2244-40D3-BE9C-1CD54A8EEFCBQ33904605-B356FCDD-4048-46A7-BD72-2C2A47B0EB62Q34067653-E19C3BF8-546D-44C4-BA76-FCFEF8325899Q34530430-14553D81-C993-4F0E-9687-76AB78536988Q34570761-EE784B4B-4CB4-4A85-99E9-6A748BF0E0CFQ34710952-AFC85B43-1EE2-4FD0-876C-FE01439250D6Q34980631-CDADFC63-9A1D-4A1E-8FA9-02A4A35325C5Q35123617-4B2CD530-0D09-4C96-B961-84F6B6FBA97EQ35376486-479E9E9E-1D7C-4114-9D7C-418B4E602CD6Q35779935-DBE9688A-A5F2-4235-BD54-1E7A60DF759CQ35897411-B95B3312-FBAE-4984-9EFD-5D430ED1AF14Q36156072-7C097AF5-D59F-4911-8E3F-BC4D1C7F88F1Q36170175-378A1803-A2BA-497A-B68B-00460E93CB8FQ36170393-DBB8B275-A523-4865-A481-AFAFA063707AQ36404911-A94F7412-C9E5-4B76-9AE5-71C1A44FC21AQ37064426-BAF2657C-8C67-4FF4-A9AD-81B2DE55EE16Q37731152-B1A551D1-06B1-4CEF-A353-D6E3C64862D1Q37776289-D6F4A001-D2C3-49EF-83D8-0A48C119A2A7Q37898048-1401590B-855B-4F74-B2E3-5E4673EFC87CQ38061936-AA78BDC4-BDBF-42DE-9B98-56226921D7B4Q38191163-F45912A8-24F7-446E-8A62-9583C6273D9CQ38224821-AE71C91E-951A-4268-B043-B0BA3F8A1D40Q38581888-E29510E0-8F4D-41EE-A702-9D8FDBDAED06Q38761594-76B35FB0-22C1-4EE9-BE33-0637D64D31D8Q38812466-3D7CBCCC-6D89-4D64-8E3B-F90343D6858CQ39245698-95E53B54-0D5A-4BBA-8C51-FF7EFD3CF45EQ39364483-C8B14BEF-B80F-4E07-9ADF-38099D762E2FQ39782444-04CE0ECE-D149-4021-B0BE-52951E921FA7Q40494955-F16AD73E-D244-4474-959E-561F034DACE9Q41086553-90247691-2918-4BE5-ADA0-8F0C84F401D5Q41453602-80FBC202-2B93-4350-8A03-089CC6DB21A0Q42555616-3A7D1435-BD4C-4BEF-BA3A-5463F8A58E52Q42727682-8EAE3654-A8D9-44C2-A339-A50929D72180Q42742948-7A11BABC-C277-4950-B09C-3EA57061AC90Q43054872-E08BF3E3-385A-471F-82B0-2F4AF2545D78Q43732842-DF64341B-432E-4EC4-BEF5-6C1C2685CBE5Q44215501-0AC0CDCF-73D0-4EEB-8BB4-DA0504965DA7
P2860
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Clinical trial of clarithromyc ...... due to Mycobacterium chelonae.
@en
Clinical trial of clarithromycin for cutaneous
@nl
type
label
Clinical trial of clarithromyc ...... due to Mycobacterium chelonae.
@en
Clinical trial of clarithromycin for cutaneous
@nl
prefLabel
Clinical trial of clarithromyc ...... due to Mycobacterium chelonae.
@en
Clinical trial of clarithromycin for cutaneous
@nl
P2093
P1476
Clinical trial of clarithromyc ...... due to Mycobacterium chelonae.
@en
P2093
Brennan PJ
Wallace RJ Jr
P304
P356
10.7326/0003-4819-119-6-199309150-00006
P407
P577
1993-09-01T00:00:00Z